Prosecution Insights
Last updated: November 04, 2026
Application No. 18/683,533

A Heat-Curable-Reaction-Resin Mixture

Non-Final OA §102§103§112
Filed
Feb 14, 2024
Priority
Aug 17, 2021 — EU 21191667.1 +1 more
Examiner
WOODWARD, ANA LUCRECIA
Art Unit
1765
Tech Center
1700 — Chemical & Materials Engineering
Assignee
Huntsman Advanced Materials Licensing (Switzerland) GmbH
OA Round
1 (Non-Final)
74%
Grant Probability
Favorable
1-2
OA Rounds
0m
Est. Remaining
90%
With Interview

Examiner Intelligence

Grants 74% — above average
74%
Career Allowance Rate
926 granted / 1258 resolved
+8.6% vs TC avg
Strong +16% interview lift
Without
With
+16.2%
Interview Lift
resolved cases with interview
Typical timeline
2y 8m
Avg Prosecution
48 currently pending
Career history
1304
Total Applications
across all art units

Statute-Specific Performance

§101
0.7%
-39.3% vs TC avg
§103
35.0%
-5.0% vs TC avg
§102
17.4%
-22.6% vs TC avg
§112
35.8%
-4.2% vs TC avg
Black line = Tech Center average estimate • Based on career data from 1258 resolved cases

Office Action

§102 §103 §112
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Election/Restrictions Applicants’ election with traverse of the compound A species and the mixture species comprising a polyfunctional isocyanate, an epoxy resin and a cure accelerator in the reply filed on September 16, 2026 is acknowledged. The traversal is on the ground(s) that the species are not separate species. This is not found persuasive because the species require a different field of search (e.g., searching different classes/subclasses or electronic resources, or employing different search strategies). Moreover, applicants have not submitted evidence or identified such evidence now of record showing the inventions to be obvious variants or clearly admitted on the record that this is the case. In either instance, if the examiner finds one of the inventions unpatentable over the prior art, the evidence or admission may be used in a rejection under 35 U.S.C. 103 or pre-AIA 35 U.S.C. 103(a) of the other invention. The requirement is still deemed proper and is therefore made FINAL. Claims 13 and 14 are withdrawn from further consideration pursuant to 37 CFR 1.142(b), as being drawn to a nonelected species, there being no allowable generic or linking claim. Applicants timely traversed the restriction (election) requirement in the reply filed on September 16, 2026. Claim Rejections - 35 USC § 112 Claims 1-12 and 15 are rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. In claim 1, it is unclear whether the “polyfunctional” term defining the isocyanate refers to plural isocyanate functional groups or to more than one type of functional groups inclusive of non-isocyanate functional groups. That is, it is unclear whether a polyisocyanate is being claimed. In claim 2, it is unclear how the hexahydrophthalic acid diglycidyl ester further defines the glycidyl ether per claim 1. In claims 3 and 7, the term "preferably" renders the claims indefinite because it is unclear whether the limitations following the term are part of the claimed invention. See MPEP § 2173.05(d). In claim 5, it is unclear whether the “above mentioned polyisocyanates” defining the isocyanate based prepolymers refer only to the antecedently-recited polyphenylene polymethylene polyisocyanate or modified polyisocyanates. In claim 9, there is no express antecedent basis from claim 1 for either “fibers” or “electrical components”. In claim 15, the phrase "such as" renders the claim indefinite because it is unclear whether the limitations following the phrase are part of the claimed invention. See MPEP § 2173.05(d). In claim 15, it is unclear how the articles per claim 12, which are already electrical components encapsulated with the reaction resin mixture, further define an encapsulation material for electrical components. Claim Rejections - 35 USC § 102/103 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. (a)(2) the claimed invention was described in a patent issued under section 151, or in an application for patent published or deemed published under section 122(b), in which the patent or application, as the case may be, names another inventor and was effectively filed before the effective filing date of the claimed invention. The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. Claims 1-9, 11, 12 and 15 are rejected under 35 U.S.C. 102(a1) and (a2) as anticipated by or, in the alternative, under 35 U.S.C. 103 as obvious over US 4631306 (Markert). As to claims 1 and 2, Markert discloses a heat-curable reaction mixture D suitable as an insulating material comprising: a) a polyepoxide inclusive of cycloaliphatic epoxies such as hexahydrophthalic acid diglycidyl ester (HHGE) (C9:61-62, Tables 10 and 11) (meets Applicants’ epoxy compound A); b) a polyisocyanate (meets Applicants’ polyfunctional isocyanate); and c) a boron trichloride-amine complex hardening catalyst (Table 10) (meets Applicants’ boron trichloride-amine complex cure accelerator) (e.g., abstract, C2:11, C9:61-C10:11, Tables 6 and 10-12, examples, claims). Markert discloses the heat-curable reaction mixtures are suitable as casting and impregnating materials in the electrical industry (e.g., C1:12-30, C7:68, examples), but does not expressly teach using them for impregnating or encapsulating coils, stators or rotors in electric engines. Case law holds that if the prior art fully and intrinsically sets forth all of the limitations of the claimed invention, and the preamble merely states the purpose or intended use of the invention, that said preambular statement is of no significance to claim construction. The intended use of the claimed invention must result in a structural difference between the claimed invention and the prior art in order to patentably distinguish the claimed invention from the prior art. If the prior art structure is capable of performing the intended use, then it meets the claim. See MPEP.§ 2111.01. As to claim 3, Markert’s heat-curable reaction mixture D has a mole ratio of epoxy to isocyanate groups (EP:IC) of 1:1 (meets Applicants ratio). As to claims 4 and 5, Markert’s heat-curable reaction mixture D comprises the aromatic isomeric diphenylmethanediisocyanate (MDI) (Table 10) which necessarily includes 2,4’ MDI and 4,4’-MDI. As to claims 6 and 7, Markert’s heat-curable reaction mixture D comprises 2.0 wt.% boron trichloride-dimethylbenzylamine adduct (BCl3/DMBA). As to claim 8, Markert discloses heat cured compositions (Examples 1 to 5). As to claims 9 and 12, Markert discloses casting the heat-curable reaction mixture D onto a rod (i.e., electrical component) followed by curing at 200°C (Examples 1 to 5). Claim 11 is included in this rejection as it merely defines the alternative fiber embodiment which is optional. As to claim 15, Markert discloses the heat-curable reaction mixtures are suitable as casting and impregnating materials in the electrical industry. Markert anticipates the above rejected claims in that it is reasonably believed that the exemplified heat-curable reaction mixture D is capable of performing the presently claimed intended use. In the alternative, given that Markert discloses the reaction mixtures are used as casting and impregnating materials in the electrical industry, it would have been obvious to one having ordinary skill in the art to use them for casting or impregnating any suitable electrical component (inclusive of those presently claimed) with the reasonable expectation of success. Claim Rejections - 35 USC § 103 Claims 1-12 and 15 are rejected under 35 U.S.C. 103 as being unpatentable over US 4631306 (Markert) described hereinabove in view of US 4220731 (Zuppinger) and US 5036135 (von Gentzkow) Further as to claims 1 and 2, Markert discloses the use of (cyclo)aliphatic epoxides (C9:61-63) which implicitly include the presently claimed glycidyl ethers of (cyclo)aliphatic polyalcohols. In this regard, Zuppinger, directed to similar-such heat-curable reaction mixtures, discloses the viable use of polyglycidyl ethers obtained by etherification of (cyclo)aliphatic diols such as butylene glycol, hexane diol, glycerol, etc. (e.g., abstract, C2:65-C3;5). Further as to the presently claimed use, von Gentzkow discloses similar-such heat-curable reaction mixtures are used for the casting and encasing of electronic components such as windings and printed circuit boards (e.g., abstract, C2:1-2, C7:14-22). Thus, it would have been within the purview of one having ordinary skill in the art to use Markert’s heat-curable reaction mixture in similar applications. As to claim 3, Markert’s heat-curable reaction mixture D has a mole ratio of epoxy to isocyanate groups (EP:IC) of 1:1 (meets Applicants ratio). As to claims 4 and 5, Markert’s heat-curable reaction mixture D comprises the aromatic isomeric diphenylmethanediisocyanate (MDI) (Table 10) which necessarily includes 2,4’ MDI and 4,4’-MDI. As to claims 6 and 7, Markert’s heat-curable reaction mixture D comprises 2.0 wt.% boron trichloride-dimethylbenzylamine adduct (BCl3/DMBA). As to claim 8, Markert discloses heat cured compositions (Examples 1 to 5). As to claims 9, 10 and 12, Markert discloses casting the heat-curable reaction mixture D onto a rod (i.e., electrical component) followed by curing at 200°C (Examples 1 to 5). Moreover, given von Gentzkow’s disclosure, it would have been within the purview of one having ordinary skill in the art to use Markert’s heat-curable reaction mixture in similar applications, e.g., for the casting and encasing of electronic components such as windings and printed circuit boards Claim 11 is included in this rejection as it merely defines the alternative fiber embodiment which is optional. As to claim 15, Markert discloses the heat-curable reaction mixtures are suitable as casting and impregnating materials in the electrical industry. In view of von Gentzkow’s disclosure, it would have been within the purview of one having ordinary skill in the art to use Markert’s heat-curable reaction mixture in similar applications. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to Ana L Woodward whose telephone number is (571)272-1082. The examiner can normally be reached M-F 8am-5pm. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Heidi Kelley can be reached at 571-270-1831. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /ANA L. WOODWARD/Primary Examiner, Art Unit 1765
Read full office action

Prosecution Timeline

Feb 14, 2024
Application Filed
Oct 19, 2026
Non-Final Rejection mailed — §102, §103, §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12781039
GRANULAR BODY AND USE THEREOF
5y 1m to grant Granted Nov 03, 2026
Patent 12781036
COMPOSITION INCLUDING AN ACRYLIC POLYMER, A WATER-REPELLENT POLYMER, AND AN ULTRAVIOLET LIGHT STABILIZER AND RELATED ARTICLES AND METHODS
3y 10m to grant Granted Nov 03, 2026
Patent 12781047
Polycarbonate Composition With High Comparative Tracking Index
3y 0m to grant Granted Nov 03, 2026
Patent 12774370
STABILIZED PROTEIN IONIC LIQUID APPLICATIONS
5y 0m to grant Granted Oct 27, 2026
Patent 12767760
MULTIBLOCK COPOLYMER CONTAINING POLYLACTIC ACID AND POLYAMIDE FOR TOUGHENING POLYLACTIC ACID AND METHOD FOR PREPARING THE SAME
3y 1m to grant Granted Oct 20, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
74%
Grant Probability
90%
With Interview (+16.2%)
2y 8m (~0m remaining)
Median Time to Grant
Low
PTA Risk
Based on 1258 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month